Saturday, October 17, 2015: 8:05 AM
Eun-Young Rha, MD, PhD
,
Plastic and Reconstructive Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, South Korea
Jong Won Rhie, MD, PhD
,
The Catholic University of Korea, Seoul, South Korea
Abstract
Purpose: One of the
CCBs, verapamil is clinically effective for the treatment of HTS when injected via
an intralesional route.1 It is, however, a disadvantageous modality
in that it causes pain, limits the indications and requires frequent outpatient
visits. We have developed a novel treatment modality based on topical
application of the silicone gel sheet (SGS) with verapamil microparticles at varying
treatment doses. Thus, we examined its effects on hypertrophic scar (HTS) in a
rabbit ear wound model.
Methods and materials: We used ten New Zealand White (NZW) rabbits, where 80 wounds were
created. We divided them into five groups (the control group, the pure SGS
group, and the SGS+verapamil 0.25,
2.5 and 25 mg/g groups). Histopathologic findings were quantified based on the scar elevation index (SEI) and fibroblast and
capillary counts.
Results: There
was a significant difference in the mean SEI, fibroblast counts, and capillary
counts between five groups (the control group, the
pure SGS group (Fig. 1), and the
SGS+verapamil 0.25, 2.5 (Fig. 2) and 25 mg/g groups). (P
< 0.05). The median SEI was significantly lower in the SGS+verapamil 2.5
mg/g group, as compared with the pure SGS group (1.2 vs. 2.2). The
median number of fibroblasts was significantly lower in the SGS+verapamil 0.25
mg/g group, as compared with the pure SGS group (172.5 vs. 243). The
median number of capillary lumina in the control group (29.5) was the
significantly highest of the five groups. But there was no significant
difference in the median number of capillary lumina between the pure SGS group,
the SGS+verapamil 0.25 mg/g group, the SGS+verapamil 2.5 mg/g group and the
SGS+verapamil 25 mg/g group (28.5, 18, 20 and 18, respectively).
Conclusions: A
topical application of the SGS with verapamil microparticles might be a novel,
effective treatment method in a rabbit model of HTS.
Reference
1.
Doong H, Dissanayake S,
Gowrishankar TR, LaBarbera MC, Lee RC. The 1996 Lindberg Award. Calcium
antagonists alter cell shape and induce procollagenase synthesis in keloid and
normal human dermal fibroblasts. J Burn Care Rehabil 1996; 17: 497-514.
Figure legends
Fig. 1. Histopathologic findings of the pure SGS group.
Fig. 2. Histopathologic findings of the SGS+verapamil 2.5 mg/g
group.